Trial site
HonorHealth
Scottsdale, Arizona 85258, United StatesNot linked to an institution yet
- 15running trials
- 17closed trials
The trials here
What the 33 trials at this site are about, from their registry records.
- Phase
- Phase 18 trials
- Phase 26 trials
- Phase 1/24 trials
- Phase 41 trial
- Status
- Completed9 trials
- Recruiting8 trials
- Terminated8 trials
- Active, not recruiting6 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Abbott Medical Devices4 trials
- Eli Lilly and Company2 trials
- Pfizer2 trials
- Agenus Inc.1 trial
- Alleviant Medical, Inc.1 trial
- and 23 more
Running trials
Not yet recruiting
A Study of LY4336619 in Adult Participants With Advanced Solid Tumors
NCT07928258· Phase 1· Eli Lilly and Company· Source
Recruiting
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
NCT07659795· Phase 2· Verastem, Inc.· Source
Contact: Sunil Sharma, MD
Recruiting
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
NCT07284758· Phase 2· C4 Therapeutics, Inc.· Source
Contact: Rizwan Khawaja, MD
Recruiting
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
NCT06964464· Phase 4· University of Rochester· Source
Contact: Geoffrey Jao, MD
Active, not recruiting
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
NCT07021066· Phase 1· SystImmune Inc.· Source
Active, not recruiting
TECTONIC CAD IVL IDE Study
NCT06885177· Abbott Medical Devices· Source
Recruiting
Serranator POINT FORCE Registry
NCT06687590· Cagent Vascular LLC· Source
Contact: Ayda Aliyari
Active, not recruiting
Esprit BTK Post-Approval Study
NCT06656364· Abbott Medical Devices· Source
Recruiting
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
NCT06559891· SoniVie Inc.· Source
Contact: Taral Patel, MD
Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
NCT06400472· Phase 1· Eli Lilly and Company· Source
Contact: Muhammad Khawaja (principal investigator)
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638· Orchestra BioMed, Inc· Source
Contact: Steven J. Evans, MD
Recruiting
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
NCT05800665· Phase 1· Genentech, Inc.· Source
Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
NCT05064709· Impulse Dynamics· Source
Contact: Rachel Hultman
Active, not recruiting
A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma
NCT04047251· Phase 1· Fujifilm Pharmaceuticals U.S.A., Inc.· Source
Active, not recruiting
SyncAV Post-Market Trial
NCT04100148· Abbott Medical Devices· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:
NCT06676072· Abbott Medical Devices· Source
Completed
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
NCT05630183· Phase 2· Agenus Inc.· Source
Recruiting
Pancreatic Cancer Detection Consortium
NCT06388967· City of Hope Medical Center· Source
Contact: Ajay Goel, PhD
Completed
Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
NCT05669599· Phase 2· Amgen· Source
Recruiting
Alleviant ALLAY-HF Study
NCT05685303· Alleviant Medical, Inc.· Source
Contact: Jennifer Olson
Terminated
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
NCT05130255· Phase 1· Y-mAbs Therapeutics· Source
Completed
Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
NCT05318092· Angiodynamics, Inc.· Source
Completed
HCW9218 for Advanced Pancreatic Cancer
NCT05304936· Phase 1/2· ImmunityBio, Inc.· Source
Completed
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors
NCT05479812· Phase 1· Werewolf Therapeutics, Inc.· Source
Terminated
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT05119335· Phase 1/2· NiKang Therapeutics, Inc.· Source
Completed
A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis
NCT05006352· Phase 1· Denali Therapeutics Inc.· Source
Terminated
BATwire Implant Kit Study
NCT04600791· CVRx, Inc.· Source
Recruiting
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT04606446· Phase 2· Pfizer· Source
Terminated
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
NCT04383210· Phase 2· Elevation Oncology· Source
Terminated
A Study of PF-06873600 in People With Cancer
NCT03519178· Phase 1/2· Pfizer· Source
Completed
The DETOUR 2 Clinical Trial
NCT03119233· Endologix· Source
Completed
A Study of FORE8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors
NCT02428712· Phase 1/2· Fore Biotherapeutics· Source
Report an error